| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Apogee Therapeutics, Inc.'s insiders have reduced their positions by a net 137,400 shares worth roughly $17.9M. In the past 30 days, 0 insiders bought and 1 sold.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), APGE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 920.9K | $124.18M | - | |
| Other | 174.0K | $23.46M | -5,500 | |
| CFO | 158.4K | $21.35M | - | |
| Dir | 7.7K | $1.03M | - | |
| Dir | 7.7K | $1.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 15,000 | $40.58 | $608,700.00 | -1.1% | -13.9% | +50.3% | |
| Jan 8, 2025 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 15,000 | $48.85 | $732,692.88 | -0.6% | -41.5% | +57.4% | |
| Jan 2, 2025 | Dambkowski Carl47 | Chief Medical Officer | Sale+OE | 4,085 | $46.94 | $191,739.64 | -0.5% | -19.8% | +60.7% | |
| Dec 12, 2024 | McKenna Mark C. | Director | Buy | 20,000 | $49.54 | $990,775.00 | +266.7% | -13.1% | +73.9% | |
| Dec 11, 2024 | Dambkowski Carl47 | Chief Medical Officer | Sale+OE | 4,540 | $48.76 | $221,362.70 | -0.9% | -17.4% | +56.9% | |
| Dec 4, 2024 | Dambkowski Carl47 | Chief Medical Officer | Sell | 6,665 | $46.07 | $307,056.55 | -2.5% | -41.6% | +45.1% | |
| Dec 4, 2024 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 15,000 | $46.58 | $698,653.68 | -0.6% | -41.6% | +45.1% | |
| Nov 6, 2024 | Dambkowski Carl47 | Chief Medical Officer | Sell | 6,665 | $59.12 | $394,041.10 | -1.2% | -31.2% | -6.5% | |
| Nov 6, 2024 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 15,000 | $59.22 | $888,320.00 | -0.6% | -31.2% | -6.5% | |
| Oct 2, 2024 | Dambkowski Carl47 | Chief Medical Officer | Sell | 6,665 | $56.26 | $374,953.90 | -1.2% | -19.4% | -29.6% |